The emerging treatment of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment